Hainan Shuangcheng Pharmaceuticals (002693.SZ) passed the drug GMP compliance inspection.
Hainan Shuangcheng Pharmaceuticals (002693.SZ) announced that the company recently received the "Drug GMP Compliance Inspection Notification" approved and issued by the Hainan Provincial Medical Products Administration. Passing this drug GMP compliance inspection indicates that the production quality management system of the above inspection scope and the related workshops and production lines complies with the requirements of the "Good Manufacturing Practice for Drugs," which is conducive to the company maintaining stable production capacity and meeting market demand.
Hainan Shuangcheng Pharmaceuticals (002693.SZ) announced that the company recently received the "Drug GMP Compliance Inspection Notification" approved and issued by the Hainan Provincial Medical Products Administration. Passing this drug GMP compliance inspection indicates that the production quality management system of the above inspection scope and the relevant workshops and production lines complies with the requirements of the "Good Manufacturing Practice for Drugs," which is conducive to the company maintaining stable production capacity and meeting market demand.
Related Articles
SINOMAX GROUP (01418): For 2024 and 2025, under the regional revenue classification, the revenue attributable to the United States, together with the revenue attributable to products ultimately distributed to the United States, was approximately HK$1.677 billion and HK$1.933 billion, respectively.
CH NETCOMTECH (08071) Appoints Baker Tilly Hong Kong as New Auditor
CTF SERVICES (00659) intends to sell 100% equity interest in Man Cheuk, 25% equity interest in Jingzhu, and 25% equity interest in Yuezhao.
SINOMAX GROUP (01418): For 2024 and 2025, under the regional revenue classification, the revenue attributable to the United States, together with the revenue attributable to products ultimately distributed to the United States, was approximately HK$1.677 billion and HK$1.933 billion, respectively.
CH NETCOMTECH (08071) Appoints Baker Tilly Hong Kong as New Auditor
CTF SERVICES (00659) intends to sell 100% equity interest in Man Cheuk, 25% equity interest in Jingzhu, and 25% equity interest in Yuezhao.
